Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estramustine binding protein in human brain-tumor tissue.

E von Schoultz1, T Bergenheim, K Grankvist

  • 1Department of Oncology, University Hospital, Umeå, Sweden.

Journal of Neurosurgery
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer in young adulthood - classifying the intensity of treatment.

Acta oncologica (Stockholm, Sweden)·2022
Same author

Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3).

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Age and surgical outcome of low-grade glioma in Sweden.

Acta neurologica Scandinavica·2018
Same author

No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy.

Neoplasma·2017
Same author

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Estramustine binding protein (EMBP) was found in human brain tumors at higher concentrations than in normal brain tissue. This suggests estramustine may be effective for treating brain cancers.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Estramustine is an anticancer drug used for advanced prostatic carcinoma.
  • Estramustine binding protein (EMBP) is crucial for its cytotoxic effects.
  • EMBP has been detected in rat and human prostate cancer tissues.

Purpose of the Study:

  • To investigate the presence and concentration of EMBP in human brain tumor tissues.
  • To evaluate the potential of estramustine as a therapeutic agent for brain tumors based on EMBP presence.

Main Methods:

  • Radioimmunoassay (RIA) was used to quantify EMBP levels.
  • EMBP concentrations were measured in astrocytomas, meningiomas, epileptic brain tissue, and normal brain tissue.

Main Results:

Related Experiment Videos

  • Significant levels of EMBP were detected in human brain tumor tissues (astrocytomas and meningiomas).
  • EMBP concentrations in tumors were significantly higher compared to normal brain and epileptic brain tissues.
  • Previous studies showed estramustine's antiproliferative effects on glioma cells.

Conclusions:

  • The presence of EMBP in brain tumors suggests a potential for selective binding and therapeutic effectiveness of estramustine.
  • Estramustine may represent a promising treatment option for certain human brain tumors.